CONSULT WITH US
CJC-1295 & Ipamorelin

CJC-1295 & Ipamorelin

SKU N/A Category Tags , ,
GHRH analog + GH secretagogue

A synergistic stack that stimulates natural growth hormone release — enhancing muscle growth and fat loss while improving sleep quality and recovery.

Product price :

د.إ 850.00

Additional information

Directions

SC 100–200 mcg twice daily; or 1–2 nasal sprays per nostril once daily.
Key Benefits

Increased muscle mass and strength
Accelerated fat loss via enhanced metabolism
Improved sleep quality and recovery
Boosted immune function and hormonal balance

03 / More information

More information

OVERVIEW

What is CJC-1295 & Ipamorelin?

INTRODUCTIONCJC-1295 & Ipamorelin are two research peptides that are often studied together because they can influence the body’s growth hormone (GH) signaling pathway. CJC-1295 is a synthetic analogue of growth hormone–releasing hormone (GHRH). It is designed to stimulate the pituitary gland to release growth hormone and, depending on the formulation, may produce a relatively prolonged effect on GH signaling. Ipamorelin is a growth hormone secretagogue that acts primarily through ghrelin receptors. Rather than supplying growth hormone directly, it is intended to encourage the body to release its own GH.

See more

Why they are combined

DUAL MECHANISMCJC-1295 and Ipamorelin act through different mechanisms, which is why they are commonly discussed as a combination. CJC-1295 works through the GHRH pathway, while Ipamorelin works through the ghrelin-receptor pathway. Together, they may produce a stronger stimulation of GH release than either mechanism alone.

Research areas

AREAS OF INTERESTThe combination has attracted interest in research
involving:

  • Growth hormone regulation
  • Muscle and tissue recovery
  • Body composition
  • Connective-tissue and bone metabolism
  • IGF-1 signaling
  • General tissue-repair pathways

However, many claims regarding significant muscle growth, fat loss, or enhanced athletic performance are based on limited evidence and should not be considered established clinical effects.

Safety considerations

POTENTIAL CONCERNSIncreasing GH and IGF-1 activity can potentially affect blood glucose, fluid balance, joints, and other tissues. Possible unwanted effects may include:

  • Headache
  • Dizziness
  • Water retention
  • Joint discomfort
  • Changes in glucose regulation

The long-term safety of using this peptide combination in healthy individuals has not been adequately established.

In summary

KEY TAKEAWAYCJC-1295 & Ipamorelin are research peptides that target different pathways involved in natural growth hormone release. CJC-1295 acts through the GHRH pathway, while Ipamorelin acts through ghrelin receptors. Their combination is therefore of interest in research concerning GH regulation, recovery, tissue metabolism, and body composition, but more high-quality human research is needed to establish their benefits and long-term safety.